What's right: new rectal cancer drug shows 100% positive response
UID: eaynwovfmk4targ3q7bjxatze4c
Revision: vaynwovf4542aratibpfs53y5a4
The new drug Dostarlimab guides the body's immune system to recognise the cancer cells as harmful and kill them. Patients who followed the six months of treatment showed a complete clinical response with no evidence of tumours during follow-up exams.
| # | MediaType | Title | FileWidgets |
|---|---|---|---|
| 1 | audio/mpeg | What's right: new rectal cancer drug shows 100% positive response |